UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer

Cancer biology & therapy, 2010-09, Vol.10 (5), p.495-504

2010

Volltextzugriff (PDF)

ADAR1 silencing-induced HUVEC apoptosis is mediated by FGFR2 under hypoxia stress

Drug design, development and therapy, 2018-01, Vol.12, p.4181-4189

2018

Volltextzugriff (PDF)

Inflammatory Mediators Suppress FGFR2 Expression in Human Keratinocytes to Promote Inflammation

Molecular and cellular biology, 2024, Vol.44 (11), p.489-504

2024

Volltextzugriff (PDF)

Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design

Future oncology (London, England), 2019-06, Vol.15 (18), p.2073-2082

2019

Volltextzugriff (PDF)

Fibroblast growth factor receptor 2: a therapeutic target in gastric cancer

Expert review of gastroenterology & hepatology, 2013-11, Vol.7 (8), p.759-765

2013

Volltextzugriff (PDF)

Targeting of human fibroblast growth factor receptor 2 by a novel specific nanobody

Preparative biochemistry & biotechnology, 2024, Vol.54 (3), p.307-316

2024

Volltextzugriff (PDF)

Derazantinib: an investigational drug for the treatment of cholangiocarcinoma

Expert opinion on investigational drugs, 2021-11, Vol.30 (11), p.1071-1080

2021

Volltextzugriff (PDF)

Binding of FGF2 to FGFR2 in an autocrine mode in trophectoderm cells is indispensable for mouse blastocyst formation through PKC-p38 pathway

Cell cycle (Georgetown, Tex.), 2015, Vol.14 (20), p.3318-3330

2015

Volltextzugriff (PDF)

Expression profile of FGF receptors in preimplantation ovine embryos and the effect of FGF2 and PD173074

Growth factors (Chur, Switzerland), 2015-09, Vol.33 (5-6), p.393-400

2015

Volltextzugriff (PDF)

Fibroblast Growth Factor Receptor 2 Phosphorylation on Serine 779 Couples to 14-3-3 and Regulates Cell Survival and Proliferation

Molecular and Cellular Biology, 2008-05, Vol.28 (10), p.3372-3385

2008

Volltextzugriff (PDF)

Fibroblast growth factor receptor 2 promotes the proliferation, migration, and invasion of ectopic stromal cells via activation of extracellular-signal-regulated kinase signaling pathway in endometriosis

Bioengineered, 2022-04, Vol.13 (4), p.8360-8371

2022

Volltextzugriff (PDF)

Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives

Expert opinion on pharmacotherapy, 2019-11, Vol.20 (17), p.2121-2137

2019

Volltextzugriff (PDF)

Lacrimo-Auriculo-Dento-Digital Syndrome Is Caused by Reduced Activity of the Fibroblast Growth Factor 10 (FGF10)-FGF Receptor 2 Signaling Pathway

Molecular and Cellular Biology, 2007-10, Vol.27 (19), p.6903-6912

2007

Volltextzugriff (PDF)

The Breast Cancer Susceptibility Gene Product Fibroblast Growth Factor Receptor 2 Serves as a Scaffold for Regulation of NF-κB Signaling

Molecular and Cellular Biology, 2012-11, Vol.32 (22), p.4662-4673

2012

Volltextzugriff (PDF)

Keratinocyte growth factor receptor: a therapeutic target in solid cancer

Expert opinion on therapeutic targets, 2015-10, Vol.19 (10), p.1411-1418

2015

Volltextzugriff (PDF)

Potential dual role of KGF/KGFR as a target option in novel therapeutic strategies for the treatment of cancers and mucosal damages

Expert opinion on therapeutic targets, 2012-04, Vol.16 (4), p.377-393

2012

Volltextzugriff (PDF)

FGF1 promotes the differentiation of goat intramuscular and subcutaneous preadipocytes

Animal biotechnology, 2023-11, Vol.34 (4), p.1196-1208

2023

Volltextzugriff (PDF)

KGFR as a possible therapeutic target in middle ear cholesteatoma

Acta oto-laryngologica, 2014-11, Vol.134 (11), p.1121-1127

2014

Volltextzugriff (PDF)

An Intronic Splicing Silencer Causes Skipping of the IIIb Exon of Fibroblast Growth Factor Receptor 2 through Involvement of Polypyrimidine Tract Binding Protein

Molecular and Cellular Biology, 2000-10, Vol.20 (19), p.7388-7400

2000

Volltextzugriff (PDF)

Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib

OncoTargets and therapy, 2021-01, Vol.14, p.5145-5160

2021

Volltextzugriff (PDF)

Lack of pharmacokinetic interaction between derazantinib and naringin in rats

Pharmaceutical biology, 2023-12, Vol.61 (1), p.514-519

2023

Volltextzugriff (PDF)

Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents

Pharmacogenomics, 2014-02, Vol.15 (3), p.375-384

2014

Volltextzugriff (PDF)

Decoupling the dynamic mechanism revealed by FGFR2 mutation-induced population shift

Journal of biomolecular structure & dynamics, 2024-03, Vol.42 (4), p.1940-1951

2024

Volltextzugriff (PDF)

Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma

OncoTargets and therapy, 2022-01, Vol.15, p.1047-1055

2022

Volltextzugriff (PDF)

Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer

OncoTargets and therapy, 2021-01, Vol.14, p.4149-4162

2021

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Journals Auto-Holdings Collection

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(159)

Publikationsform

Artikel
(199)

Sprache

Englisch
(199)

Erscheinungsjahr

n.n

Thema

Science & Technology
(186)
Life Sciences & Biomedicine
(185)
Humans
(116)
Animals
(105)
Cell Biology
(84)
Mice
(51)
Biochemistry & Molecular Biology
(48)
Female
(47)
Fibroblast Growth Factor 2 - Metabolism
(40)
Fibroblast Growth Factor 2 - Pharmacology
(34)
Rats
(31)
Receptor, Fibroblast Growth Factor, Type 2 - Genetics
(31)
Male
(29)
Receptors, Fibroblast Growth Factor - Metabolism
(29)
Cells, Cultured
(28)
Endocrinology & Metabolism
(28)
Receptor, Fibroblast Growth Factor, Type 2
(27)
Signal Transduction
(27)
Receptors, Fibroblast Growth Factor - Genetics
(25)
Cell Line
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer

ADAR1 silencing-induced HUVEC apoptosis is mediated by FGFR2 under hypoxia stress

Inflammatory Mediators Suppress FGFR2 Expression in Human Keratinocytes to Promote Inflammation

Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design

Fibroblast growth factor receptor 2: a therapeutic target in gastric cancer

Targeting of human fibroblast growth factor receptor 2 by a novel specific nanobody

Derazantinib: an investigational drug for the treatment of cholangiocarcinoma

Binding of FGF2 to FGFR2 in an autocrine mode in trophectoderm cells is indispensable for mouse blastocyst formation through PKC-p38 pathway

Expression profile of FGF receptors in preimplantation ovine embryos and the effect of FGF2 and PD173074

Fibroblast Growth Factor Receptor 2 Phosphorylation on Serine 779 Couples to 14-3-3 and Regulates Cell Survival and Proliferation

Fibroblast growth factor receptor 2 promotes the proliferation, migration, and invasion of ectopic stromal cells via activation of extracellular-signal-regulated kinase signaling pathway in endometriosis

Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives

Lacrimo-Auriculo-Dento-Digital Syndrome Is Caused by Reduced Activity of the Fibroblast Growth Factor 10 (FGF10)-FGF Receptor 2 Signaling Pathway

The Breast Cancer Susceptibility Gene Product Fibroblast Growth Factor Receptor 2 Serves as a Scaffold for Regulation of NF-κB Signaling

Keratinocyte growth factor receptor: a therapeutic target in solid cancer

Potential dual role of KGF/KGFR as a target option in novel therapeutic strategies for the treatment of cancers and mucosal damages

FGF1 promotes the differentiation of goat intramuscular and subcutaneous preadipocytes

KGFR as a possible therapeutic target in middle ear cholesteatoma

An Intronic Splicing Silencer Causes Skipping of the IIIb Exon of Fibroblast Growth Factor Receptor 2 through Involvement of Polypyrimidine Tract Binding Protein

Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib

Lack of pharmacokinetic interaction between derazantinib and naringin in rats

Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents

Decoupling the dynamic mechanism revealed by FGFR2 mutation-induced population shift

Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma

Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer

Aktive Filter

Suchergebnisse filtern